Literature DB >> 8811934

Insular cortex lesions impair the acquisition of conditioned immunosuppression.

V Ramírez-Amaya1, B Alvarez-Borda, C E Ormsby, R D Martínez, R Pérez-Montfort, F Bermúdez-Rattoni.   

Abstract

Conditioned immunosuppression can be readily obtained in animals by associating a taste with an immunosuppressive drug. On subsequent exposure to the conditioned taste, the animals show an attenuated immune response and also exhibit a conditioned taste aversion. It has been established that insular cortex lesions disrupt the acquisition of conditioned taste aversion. The effect of NMDA-induced lesions in either the insular cortex or the parietal cortex of male Wistar rats was evaluated in the acquisition of conditioned immunosuppression in two experiments. Unlesioned control rats showed the conditioned immunosuppressive response after reexposure to the taste, as indicated by lower hemagglutinating titers to sheep red blood cells in the first experiment and by a decreased IgM production to ovalbumin, measured by ELISA, in the second experiment. Insular cortex-lesioned rats did not show the conditioned immunosuppression in either experiment, while parietal cortex lesions and the sham-lesioned animals presented a clear decrease of hemagglutinating titer and a low IgM production. The insular cortex lesions did not affect the normal immune response, showing normal hemagglutinating titers and IgM production when compared to nonconditioned controls. The immunosuppressive action of cyclophosphamide also remained unaltered. In conclusion, these results show that the insular cortex is essential for the acquisition of conditioned immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811934     DOI: 10.1006/brbi.1996.0011

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  8 in total

Review 1.  Brain-immune interactions and the neural basis of disease-avoidant ingestive behaviour.

Authors:  Gustavo Pacheco-López; Federico Bermúdez-Rattoni
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-12       Impact factor: 6.237

2.  Ventral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the expression of heroin-conditioned immunomodulation.

Authors:  Jennifer L Szczytkowski; Rita A Fuchs; Donald T Lysle
Journal:  J Neuroimmunol       Date:  2011-07-01       Impact factor: 3.478

3.  Electrical activity in rat cortico-limbic structures after single or repeated administration of lipopolysaccharide or staphylococcal enterotoxin B.

Authors:  Raphael Doenlen; Ute Krügel; Timo Wirth; Carsten Riether; Andrea Engler; Geraldine Prager; Harald Engler; Manfred Schedlowski; Gustavo Pacheco-López
Journal:  Proc Biol Sci       Date:  2010-11-24       Impact factor: 5.349

4.  Insula and the Immune System: More than mere Co-existence?

Authors:  Panagiotis Kerezoudis; Charles L Howe; Long-Jun Wu; Brian N Lundstrom; Jamie J Van Gompel
Journal:  Neurosci Bull       Date:  2022-06-28       Impact factor: 5.271

5.  Gustatory insular cortex lesions disrupt drug-induced, but not lithium chloride-induced, suppression of conditioned stimulus intake.

Authors:  Rastafa I Geddes; Li Han; Anne E Baldwin; Ralph Norgren; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

Review 6.  Placebo and the new physiology of the doctor-patient relationship.

Authors:  Fabrizio Benedetti
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 7.  Neuronal regulation of immunity: why, how and where?

Authors:  Maya Schiller; Tamar L Ben-Shaanan; Asya Rolls
Journal:  Nat Rev Immunol       Date:  2020-08-18       Impact factor: 53.106

8.  Central stress processing, T-cell responsivity to stress hormones and disease severity in multiple sclerosis.

Authors:  Jelena Brasanac; Stefan Hetzer; Susanna Asseyer; Joseph Kuchling; Judith Bellmann-Strobl; Kristin Ritter; Stefanie Gamradt; Michael Scheel; John-Dylan Haynes; Alexander U Brandt; Friedemann Paul; Stefan M Gold; Martin Weygandt
Journal:  Brain Commun       Date:  2022-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.